In the course of changing the technological order and the ever-increasing role of biotechnologies in the economy, medicine and pharmaceuticals, we are actively developing this direction and offering our partners a wide range of opportunities:

– Transfer of production technologies: biological substances, blood plasma preparations, monoclonal and orphan drugs, hormones, human and veterinary vaccines;

– Cooperation with Chinese enterprises, developers and manufacturers of pharmaceutical biological products at preclinical and various stages of clinical trials, allowing to consider the possibility of registering the drug in the country of technology localization, construction and equipping of production with technological equipment, as well as the release of the finished drug almost simultaneously with the original drug in the country of origin;

– Joint activities with the Russian design organization on the development of a conceptual design, adaptation in accordance with the requirements of the legislation of the EAEU countries of the technological section and other general and special design sections, with the subsequent passage of examination and obtaining a construction permit;

– Engineering (manufacture and supply of technological equipment, installation and commissioning works), localization of production by technology transfer in accordance with GMP requirements, with the mandatory release of the first five experimental batches, followed by production control and personnel training;

– Validation of the production process for compliance with the requirements stated in the transfer of technologies – pharmacopoeia of the EU, EAEU or USA countries

Download catalogues:

End-to-End Solutions for Biopharmaceuticals, 2021

Single-use Applications, 41/2022

Technology transfer in the pharmaceutical industry from China